Research Study

PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Principal Investigator 
Eduardo Navajas

Overview

Body Locations and Systems 
Diabetic Eye Problems
ClinicalTrials.gov# 
NCT03345901
Status 
Recruiting
Study Start/End 
Jun 27, 2018 to Jan 31, 2023
Locations 
Vancouver General Hospital
Name/Title 
Theresa Wiens
Phone 
604-875-4111 ext.62544
Purpose of Study 

The purpose of this study is to determine if Pemafibrate (administered to participants as part of the PROMINENT study) prevents the worsening of diabetic retinopathy or reduces the incidence of diabetic macular edema.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.